{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:51:16Z","timestamp":1794333076867,"version":"4.9.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijcha.2025.101836","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:13:39Z","timestamp":1763658819000},"page":"101836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Diagnostic and prognostic utility of heart-type fatty acid binding proteins in cardiovascular diseases and risk factors \u2212 an updated review of the literature"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7479-3224","authenticated-orcid":false,"given":"Riaz","family":"Jiffry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeisun","family":"Poornaselvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadeep","family":"Dhali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Ye Rim","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2025.101836_b0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-nutr-062220-112240","article-title":"The Multifunctional Family of Mammalian Fatty Acid- Binding Proteins","volume":"43","author":"Storch","year":"2023","journal-title":"Annu. Rev. Nutr."},{"issue":"8","key":"10.1016\/j.ijcha.2025.101836_b0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/07853890.2020.1800075","article-title":"Heart-type fatty acid-binding protein: an overlooked cardiac biomarker","volume":"52","author":"Goel","year":"2020","journal-title":"Ann. Med."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101836_b0390","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ahj.2010.05.010","article-title":"Correlation of heart-type fatty acid-binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk","volume":"160","author":"Boscheri","year":"2010","journal-title":"Am. Heart J."},{"issue":"1\u20132","key":"10.1016\/j.ijcha.2025.101836_b0395","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2006.02.032","article-title":"Plasma heart-type fatty acid-binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism","volume":"371","author":"Kaczy\u0144ska","year":"2006","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.ijcha.2025.101836_b0400","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/eurheartj\/ehl405","article-title":"Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism","volume":"28","author":"Puls","year":"2007","journal-title":"Eur. Heart J."},{"issue":"19","key":"10.1016\/j.ijcha.2025.101836_b0405","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2009.10.078","article-title":"Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism","volume":"55","author":"Dellas","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcha.2025.101836_b0410","first-page":"531","article-title":"Association of pulmonary artery obstruction index with elevated heart-type fatty acid binding protein and short-term mortality in patients with pulmonary embolism at intermediate risk","volume":"18","author":"G\u00fcl","year":"2012","journal-title":"Diagn. Interv. Radiol."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101836_b0415","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1538-7836.2008.03260.x","article-title":"Cardiac biomarkers for risk stratification in non-massive pulmonary embolism: a multicenter prospective study","volume":"7","author":"Vuilleumier","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.ijcha.2025.101836_b0420","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.thromres.2013.09.022","article-title":"The predictive value of heart-type fatty acid-binding protein is independent from symptom duration in normotensive patients with pulmonary embolism","volume":"132","author":"Lankeit","year":"2013","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101836_b0425","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/cc12735","article-title":"Plasma levels of mitochondrial and nuclear DNA in patients with massive pulmonary embolism in the emergency department: a prospective cohort study","volume":"17","author":"Arnalich","year":"2013","journal-title":"Crit. Care"},{"key":"10.1016\/j.ijcha.2025.101836_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.06.001","article-title":"Role of fatty acid binding proteins (FABPs) in cancer development and progression","volume":"62","author":"McKillop","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ijcha.2025.101836_b0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.nutr.27.061406.093710","article-title":"The emerging functions and mechanisms of mammalian fatty acid-binding proteins","volume":"28","author":"Storch","year":"2008","journal-title":"Annu. Rev. Nutr."},{"issue":"24","key":"10.1016\/j.ijcha.2025.101836_b0025","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1021\/bi000314z","article-title":"Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions","volume":"39","author":"Richieri","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijcha.2025.101836_b0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/bse0420089","article-title":"Fatty acid metabolism in adipose tissue, muscle and liver in health and disease","volume":"42","author":"Frayn","year":"2006","journal-title":"Essays Biochem."},{"issue":"9","key":"10.1016\/j.ijcha.2025.101836_b0035","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJMoa0903515","article-title":"Sensitive troponin I assay in early diagnosis of acute myocardial infarction","volume":"361","author":"Keller","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.ijcha.2025.101836_b0040","first-page":"e344","article-title":"2014 AHA\/ACC guideline for the management of patients with non\u2013ST-elevation acute coronary syndromes","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2025.101836_b0045","article-title":"Prognostic value of heart-type fatty acid-binding protein in patients with renal dysfunction","volume":"8","author":"Ishii","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcha.2025.101836_b0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12872-015-0026-0","article-title":"Ischemic biomarker heart-type fatty acid-binding protein (hFABP) in acute heart failure\u2014diagnostic and prognostic insights compared to NT-proBNP and troponin I","volume":"15","author":"Hoffmann","year":"2015","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ijcha.2025.101836_b0055","article-title":"Risk Factors for Coronary Artery Disease","author":"Brown","year":"2024","journal-title":"StatPearls. Treasure Island (FL): Statpearls Publishing"},{"key":"10.1016\/j.ijcha.2025.101836_b0060","doi-asserted-by":"crossref","unstructured":"Bajaj A, Rathor P, Sehgal V, Shetty A, Kabak B, Hosur S. Risk stratification in acute pulmonary embolism with heart-type fatty acid-binding protein: A meta-analysis. J Crit Care. 2015;30(5):1151.e1\u20137.","DOI":"10.1016\/j.jcrc.2015.05.026"},{"issue":"1","key":"10.1016\/j.ijcha.2025.101836_b0065","doi-asserted-by":"crossref","first-page":"14410","DOI":"10.1038\/s41598-018-32210-x","article-title":"The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease","volume":"8","author":"Ho","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101836_b0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijcard.2006.09.003","article-title":"Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay","volume":"119","author":"Ecollan","year":"2007","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101836_b0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1042\/CS20100435","article-title":"Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients","volume":"121","author":"Huang","year":"2011","journal-title":"Clin. Sci. (Lond.)"},{"issue":"7","key":"10.1016\/j.ijcha.2025.101836_b0080","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/aps.2018.37","article-title":"Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis","volume":"39","author":"Ye","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"1\u20132","key":"10.1016\/j.ijcha.2025.101836_b0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF01270583","article-title":"Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man","volume":"116","author":"Kleine","year":"1992","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.ijcha.2025.101836_b0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ihj.2015.06.035","article-title":"Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain","volume":"67","author":"Vupputuri","year":"2015","journal-title":"Indian Heart J."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101836_b0095","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s13273-022-00287-1","article-title":"Cardiac biomarkers and detection methods for myocardial infarction","volume":"18","author":"Kim","year":"2022","journal-title":"Mol. Cell. Toxicol."},{"key":"10.1016\/j.ijcha.2025.101836_b0100","doi-asserted-by":"crossref","unstructured":"Matsumoto S, Nakatani D, Sakata Y, Suna S, himizu M, Usami M, et al. Elevated Serum Heart-Type Fatty Acid-Binding Protein in the Convalescent Stage Predicts Long-Term Outcome in Patients Surviving Acute Myocardial Infarction. Circ J. 2013;77(4):1026\u201332.","DOI":"10.1253\/circj.CJ-12-0999"},{"issue":"2","key":"10.1016\/j.ijcha.2025.101836_b0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cardfail.2006.10.014","article-title":"Heart-type fatty acid-binding protein is more sensitive than troponin T to detect ongoing myocardial damage in chronic heart failure patients","volume":"13","author":"Niizeki","year":"2007","journal-title":"J. Card. Fail."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101836_b0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cardfail.2004.03.005","article-title":"Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure","volume":"11","author":"Arimoto","year":"2005","journal-title":"J. Card. Fail."},{"issue":"9","key":"10.1016\/j.ijcha.2025.101836_b0115","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0002-9343(02)01394-3","article-title":"Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure","volume":"113","author":"Setsuta","year":"2002","journal-title":"Am. J. Med."},{"issue":"7","key":"10.1016\/j.ijcha.2025.101836_b0120","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cardfail.2005.04.025","article-title":"Circulating levels of myocardial proteins predict future deterioration of congestive heart failure","volume":"11","author":"Sugiura","year":"2005","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcha.2025.101836_b0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2018.09.004","article-title":"Persistently elevated plasma heart-type fatty acid binding protein concentration is related with poor outcome in acute decompensated heart failure patients","volume":"487","author":"Kazimierczyk","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ijcha.2025.101836_b0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12872-015-0026-0","article-title":"Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure\u2014diagnostic and prognostic insights compared to NT-proBNP and troponin I","volume":"15","author":"Hoffmann","year":"2015","journal-title":"BMC Cardiovasc. Disord."},{"issue":"8","key":"10.1016\/j.ijcha.2025.101836_b0135","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1253\/circj.69.922","article-title":"Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure","volume":"69","author":"Niizeki","year":"2005","journal-title":"Circ J"},{"issue":"8","key":"10.1016\/j.ijcha.2025.101836_b0140","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1007\/s00246-015-1223-4","article-title":"Serum Level of Heart-Type Fatty Acid Binding Protein (H-FABP) before and after Treatment of Congestive Heart failure in Children","volume":"36","author":"Zoair","year":"2015","journal-title":"Pediatr. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101836_b0145","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.3390\/jcm9010164","article-title":"Heart-Type Fatty Acid-Binding Protein (H-FABP) and its Role as a Biomarker in Heart failure: what do we know so Far?","volume":"9","author":"Rezar","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101836_b0150","first-page":"541","article-title":"Heart-type fatty acid binding protein is related to severity and established cardiac biomarkers of heart failure","volume":"2","author":"Gruson","year":"2021","journal-title":"Adv Lab Med."},{"issue":"5","key":"10.1016\/j.ijcha.2025.101836_b0155","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1213\/ANE.0b013e3181dd9516","article-title":"Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery","volume":"111","author":"Muehlschlegel","year":"2010","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ijcha.2025.101836_b0160","doi-asserted-by":"crossref","unstructured":"Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):401S\u201328S.","DOI":"10.1378\/chest.126.3_suppl.401S"},{"issue":"3","key":"10.1016\/j.ijcha.2025.101836_b0165","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1161\/01.CIR.96.3.882","article-title":"Association between thrombolytic treatment and prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry","volume":"96","author":"Konstantinides","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcha.2025.101836_b0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.thromres.2014.10.007","article-title":"Prognostic role of heart-type fatty acid binding protein in pulmonary embolism: a meta-analysis","volume":"135","author":"Liu","year":"2015","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.ijcha.2025.101836_b0175","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1378\/chest.13-1008","article-title":"Prognostic value of plasma heart-type fatty acid-binding protein in patients with acute pulmonary embolism: a meta-analysis","volume":"146","author":"Ruan","year":"2014","journal-title":"Chest"},{"issue":"20","key":"10.1016\/j.ijcha.2025.101836_b0180","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.1996.03530440051036","article-title":"Blood pressure as a cardiovascular risk factor: prevention and treatment","volume":"275","author":"Kannel","year":"1996","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ijcha.2025.101836_b0185","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1253\/circj.72.569","article-title":"Elevated levels of both cardiomyocyte membrane and myofibril damage markers predict adverse outcomes in patients with chronic heart failure","volume":"72","author":"Setsuta","year":"2008","journal-title":"Circ J"},{"issue":"9","key":"10.1016\/j.ijcha.2025.101836_b0190","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ajh.2008.235","article-title":"Relationship between arterial stiffness and myocardial damage in patients with newly diagnosed essential hypertension","volume":"21","author":"Gedikli","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ijcha.2025.101836_b0195","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.nutr.24.012003.132155","article-title":"The insulin resistance syndrome: definition and dietary approaches to treatment","volume":"25","author":"Reaven","year":"2005","journal-title":"Annu. Rev. Nutr."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101836_b0200","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2337\/diacare.27.4.1011","article-title":"Insulin resistance, cardiovascular disease, and the metabolic syndrome: how well do the emperor\u2019s clothes fit?","volume":"27","author":"Reaven","year":"2004","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ijcha.2025.101836_b0205","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2337\/diabetes.49.5.677","article-title":"Fuel selection in human skeletal muscle in insulin resistance: a reexamination","volume":"49","author":"Kelley","year":"2000","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.ijcha.2025.101836_b0210","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s11745-001-0809-2","article-title":"A new concept of cellular uptake and intracellular trafficking of long-chain fatty acids","volume":"36","author":"Stremmel","year":"2001","journal-title":"Lipids"},{"issue":"33","key":"10.1016\/j.ijcha.2025.101836_b0215","doi-asserted-by":"crossref","first-page":"34481","DOI":"10.1074\/jbc.M314263200","article-title":"Heart fatty acid uptake is decreased in heart fatty acid-binding protein gene-ablated mice","volume":"279","author":"Murphy","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101836_b0220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1152\/physiolgenomics.00089.2003","article-title":"Transcriptional adaptations of lipid metabolism in tibialis anterior muscle of endurance-trained athletes","volume":"15","author":"Schmitt","year":"2003","journal-title":"Physiol. Genomics"},{"issue":"11","key":"10.1016\/j.ijcha.2025.101836_b0225","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.2337\/diabetes.54.11.3133","article-title":"Partial gene deletion of heart-type fatty acid-binding protein limits the severity of dietary-induced insulin resistance","volume":"54","author":"Shearer","year":"2005","journal-title":"Diabetes"},{"issue":"16","key":"10.1016\/j.ijcha.2025.101836_b0230","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.113.001941","article-title":"Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2","volume":"128","author":"Sacher","year":"2013","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ijcha.2025.101836_b0235","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.amjcard.2013.06.033","article-title":"Prevalence and prognostic role of various conduction disturbances in patients with Brugada syndrome","volume":"112","author":"Maury","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcha.2025.101836_b0240","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1540-8159.2007.00770.x","article-title":"Detectable troponin levels predict poor prognosis in patients with left ventricular dysfunction undergoing internal defibrillator implantation","volume":"30","author":"Sonel","year":"2007","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"7","key":"10.1016\/j.ijcha.2025.101836_b0245","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cardfail.2012.04.006","article-title":"Circulating heart-type fatty acid binding protein levels predict the occurrence of appropriate shocks and cardiac death in patients with implantable cardioverter-defibrillators","volume":"18","author":"Daidoji","year":"2012","journal-title":"J. Card. Fail."},{"issue":"23","key":"10.1016\/j.ijcha.2025.101836_b0250","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/eurheartj\/ehn363","article-title":"Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T","volume":"29","author":"McCann","year":"2008","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101836_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2009.08.645","article-title":"Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction","volume":"105","author":"Haltern","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"23","key":"10.1016\/j.ijcha.2025.101836_b0260","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.jacc.2009.12.062","article-title":"Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative","volume":"55","author":"Viswanathan","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101836_b0265","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jjcc.2015.04.011","article-title":"Circulating heart-type fatty acid-binding protein levels predict ventricular fibrillation in Brugada syndrome","volume":"67","author":"Daidoji","year":"2016","journal-title":"J. Cardiol."},{"issue":"14","key":"10.1016\/j.ijcha.2025.101836_b0270","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/jama.291.14.1720","article-title":"A multicenter risk index for atrial fibrillation after cardiac surgery","volume":"291","author":"Mathew","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ijcha.2025.101836_b0275","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/01.CIR.94.3.390","article-title":"Predictors of atrial fibrillation after coronary artery surgery","volume":"94","author":"Aranki","year":"1996","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ijcha.2025.101836_b0280","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1001\/jama.294.24.3093","article-title":"Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair (PAPABEAR trial)","volume":"294","author":"Mitchell","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ijcha.2025.101836_b0285","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.hrthm.2012.10.007","article-title":"Perioperative heart-type fatty acid binding protein levels in atrial fibrillation after cardiac surgery","volume":"10","author":"Rader","year":"2013","journal-title":"Heart Rhythm"},{"issue":"13","key":"10.1016\/j.ijcha.2025.101836_b0290","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/01.CIR.102.13.1530","article-title":"Predictors of atrial fibrillation after conventional and beating heart coronary surgery: a prospective, randomized study","volume":"102","author":"Ascione","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcha.2025.101836_b0295","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.athoracsur.2006.10.057","article-title":"Coronary Artery Revascularization (CARE) registry: an observational study of on-pump and off-pump coronary artery revascularization","volume":"83","author":"Palmer","year":"2007","journal-title":"Ann. Thorac. Surg."},{"issue":"5","key":"10.1016\/j.ijcha.2025.101836_b0300","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.amjcard.2011.04.017","article-title":"Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting","volume":"108","author":"Miles","year":"2011","journal-title":"Am. J. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcha.2025.101836_b0305","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jacc.2010.04.042","article-title":"The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease","volume":"56","author":"Stone","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101836_b0310","doi-asserted-by":"crossref","unstructured":"Task Force for the Diagnosis and Management of Syncope, European Society of Cardiology, European Heart Rhythm Association, Heart Failure Association, Heart Rhythm Society, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30(21):2631\u201371.","DOI":"10.1093\/eurheartj\/ehp298"},{"key":"10.1016\/j.ijcha.2025.101836_b0315","first-page":"1156","article-title":"Bedside heart-type fatty acid binding protein (H-FABP): an early predictive marker of cardiac syncope","volume":"65","author":"Sonmez","year":"2015","journal-title":"J. Pak. Med. Assoc."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101836_b0320","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.annemergmed.2014.07.452","article-title":"Outcomes in presyncope patients: a prospective cohort study","volume":"65","author":"Thiruganasambandamoorthy","year":"2015","journal-title":"Ann. Emerg. Med."},{"issue":"5","key":"10.1016\/j.ijcha.2025.101836_b0325","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/hrt.2004.043067","article-title":"Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy","volume":"92","author":"Komamura","year":"2006","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ijcha.2025.101836_b0330","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1038\/s41598-021-90395-0","article-title":"Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease","volume":"11","author":"Zamzam","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcha.2025.101836_b0335","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jvssci.2020.08.003","article-title":"Fatty acid binding protein 3 is associated with peripheral arterial disease","volume":"1","author":"Syed","year":"2020","journal-title":"JVS Vasc Sci."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101836_b0340","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4274\/jcrpe.3961","article-title":"Heart-type fatty acid binding protein level as a tool in identification of early cardiac effects of diabetic ketoacidosis","volume":"9","author":"Y\u0131lmaz","year":"2017","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101836_b0345","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s004249900180","article-title":"Heart fatty acid binding protein and cardiac troponin T plasma concentrations as markers for myocardial infarction after coronary artery ligation in mice","volume":"439","author":"Aartsen","year":"2000","journal-title":"Pflugers Arch."},{"issue":"1\u20132","key":"10.1016\/j.ijcha.2025.101836_b0350","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cccn.2004.09.001","article-title":"Fatty acid-binding proteins as plasma markers of tissue injury","volume":"352","author":"Pelsers","year":"2005","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.ijcha.2025.101836_b0355","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/ki.2015.228","article-title":"Comorbidity as a driver of adverse outcomes in people with chronic kidney disease","volume":"88","author":"Tonelli","year":"2015","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101836_b0360","doi-asserted-by":"crossref","first-page":"C69","DOI":"10.1159\/000068520","article-title":"Serum ratio of heart-type fatty acid-binding protein to myoglobin: a novel marker of cardiac damage and volume overload in hemodialysis patients","volume":"93","author":"Furuhashi","year":"2003","journal-title":"Nephron Clin. Pract."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101836_b0365","doi-asserted-by":"crossref","first-page":"311","DOI":"10.18295\/2075-0528.2806","article-title":"Serum level of heart-type fatty acid-binding protein in patients with chronic renal failure","volume":"9","author":"Al-Hadi","year":"2009","journal-title":"Sultan Qaboos Univ. Med. J."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101836_b0370","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ehf2.12414","article-title":"Worsening renal failure in patients with acute heart failure: the importance of cardiac biomarkers","volume":"6","author":"Shirakabe","year":"2019","journal-title":"ESC Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101836_b0375","first-page":"120","article-title":"Cardiac biomarkers and cardiovascular outcome in children with chronic kidney disease","volume":"13","author":"Mohammed","year":"2019","journal-title":"Iran. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101836_b0380","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.ajkd.2022.01.424","article-title":"Heart-type fatty acid binding protein, cardiovascular outcomes, and death: findings from the German CKD Cohort Study","volume":"80","author":"Schneider","year":"2022","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101836_b0385","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/clinchem\/43.1.193a","article-title":"Increased fatty acid-binding protein concentration in plasma of patients with chronic renal failure","volume":"43","author":"Gorski","year":"1997","journal-title":"Clin. Chem."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725002398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725002398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T16:42:40Z","timestamp":1764866560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906725002398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":85,"alternative-id":["S2352906725002398"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101836","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and prognostic utility of heart-type fatty acid binding proteins in cardiovascular diseases and risk factors \u2212 an updated review of the literature","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101836"}}